These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 21412886)

  • 1. Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma.
    Oliveri RS; Wetterslev J; Gluud C
    Cochrane Database Syst Rev; 2011 Mar; (3):CD004787. PubMed ID: 21412886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoembolization for intermediate HCC: is there proof of survival benefit?
    Forner A; Llovet JM; Bruix J
    J Hepatol; 2012 Apr; 56(4):984-6. PubMed ID: 22008737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.
    Swierz MJ; Storman D; Mitus JW; Hetnal M; Kukielka A; Szlauer-Stefanska A; Pedziwiatr M; Wolff R; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD012757. PubMed ID: 39119869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.
    Riemsma RP; Bala MM; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009498. PubMed ID: 23633373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman O; Elsayed Z
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011313. PubMed ID: 31978267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: a response to the Cochrane Collaboration review of 2011.
    Ray CE; Haskal ZJ; Geschwind JF; Funaki BS
    J Vasc Interv Radiol; 2011 Dec; 22(12):1693-6. PubMed ID: 22035882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter arterial chemoembolisation followed by three-dimensional conformal radiotherapy versus transcatheter arterial chemoembolisation alone for primary hepatocellular carcinoma in adults.
    Lu L; Zeng J; Wen Z; Tang C; Xu N
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012244. PubMed ID: 30776082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of people with intermediate-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Roccarina D; Majumdar A; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011649. PubMed ID: 28281295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial (chemo)embolisation versus no intervention or placebo intervention for liver metastases.
    Riemsma RP; Bala MM; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2012 Sep; (9):CD009498. PubMed ID: 22972145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
    Abdel-Rahman OM; Elsayed Z
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External beam radiotherapy for unresectable hepatocellular carcinoma.
    Abdel-Rahman O; Elsayed Z
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011314. PubMed ID: 28267205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of transcatheter arterial chemoembolisation (TACE) and thermal ablation versus TACE alone for hepatocellular carcinoma.
    Liu B; Zhang Y; Chen H; Li W; Tsochatzis E
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD013345. PubMed ID: 34981511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous ethanol injection for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD008717. PubMed ID: 32017845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review.
    Xie ZB; Ma L; Wang XB; Bai T; Ye JZ; Zhong JH; Li LQ
    Tumour Biol; 2014 Sep; 35(9):8451-9. PubMed ID: 25038916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
    Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
    Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
    Li XQ; Ling CQ
    Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous ethanol injection for liver metastases.
    Riemsma RP; Bala MM; Wolff R; Kleijnen J
    Cochrane Database Syst Rev; 2013 May; (5):CD008717. PubMed ID: 23728679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.